Enzymatica AB (publ)

Stockholm Stock Exchange ENZY.ST

Enzymatica AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -72.05 K

Enzymatica AB (publ) Net Cash Used For Investing Activities is USD -72.05 K for the year ending December 31, 2023, a 79.70% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Enzymatica AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -354.97 K, a 47.43% change year over year.
  • Enzymatica AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -675.24 K, a -15.18% change year over year.
  • Enzymatica AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -586.24 K, a -536.24% change year over year.
  • Enzymatica AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -92.14 K, a -57.51% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: ENZY.ST

Enzymatica AB (publ)

CEO Mr. Claus Egstrand
IPO Date June 14, 2011
Location Sweden
Headquarters Ideon Science Park
Employees 17
Sector Healthcare
Industries
Description

Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in Germany; Psysiomer Stop Virus brand in France; and Zerinol Virus Defense brand in Italy. Enzymatica AB was incorporated in 2007 and is headquartered in Lund, Sweden.

Similar companies

KAN.ST

Kancera AB (publ)

USD 0.09

-2.98%

ONCO.ST

Oncopeptides AB (publ)

USD 0.16

9.53%

BONEX.ST

Bonesupport Holding AB (publ)

USD 30.85

-1.29%

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

DMYD-B.ST

Diamyd Medical AB (publ)

USD 1.49

-4.08%

StockViz Staff

February 5, 2025

Any question? Send us an email